Septerna, Inc. (SEPN) Deep Dive Video

Summary

Septerna pairs a Novo-validated GPCR discovery engine with cash-rich clinical execution and oral-drug upside across injectable-dominated multi-billion-dollar markets.

View SEPN stock page · Read the SEPN research report

Loading the video player…